Distribution and elimination characteristics of 111In-DTPA-D-Phe1-octreotide and 111In-DTPA-L-Phe1-octreotide in rats

被引:10
|
作者
Laznickova, A [1 ]
Laznicek, M
Trejtnar, F
Melicharova, L
Suzuki, KH
Akizawa, H
Arano, Y
Yokoyama, A
机构
[1] Charles Univ, Fac Pharm, Res Ctr, Hradec Kralove 50005, Czech Republic
[2] Kyoto Univ, Fac Pharmaceut Sci, Sakyo Ku, Kyoto, Japan
关键词
In-111; DTPA-D-Phe(1)-octreotide; DTPA-L-Phe(1)-octreotide; biodistribution; bioelimination;
D O I
10.1007/BF03190403
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study compares distribution and elimination characteristics of In-111-DTPA-D-Phe(1)-octreotide and In-111-DTPA-L-Phe(1)-octreotide in rats and evaluated the effect of the replacement of the terminal L-phenylalanine by D-phenylalanine on pharmacokinetic profiles of the radiolabelled peptides. Both agents exhibited rapid radioactivity clearance from the blood and most organs and tissues with no systematic and significant differences in activity accumulation. The long-term retention and high radioactivity concentrations for both compounds under study were found in the kidneys and organs with a high density of somatostatin receptors, such as the pancreas and adrenals. The residence times in these organs were longer for In-111-DTPA-D-Phe(1)-octreotide in comparison with In-111-DTPA-L-Phe(1)-octreotide. The major elimination pathway for both radiolabelled peptides was relatively rapid excretion into the urine. Analysis of the renal handling by an employment of the perfused rat kidney showed that both peptides were eliminated mainly by the mechanism of glomerular filtration. Rat liver perfusion experiments confirmed a very low value of bile clearance of radioactivity for both agents under study.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 50 条
  • [1] Distribution and elimination characteristics of111In-DTPA-D-Phe1-octreotide and111In-DTPA-L-Phe1-octreotide in rats
    Alice Laznickova
    M. Laznicek
    F. Trejtnar
    L. Melicharova
    Kazuko Horuichi Suzuki
    Hiromichi Akizawa
    Yasushi Arano
    Akira Yokoyama
    European Journal of Drug Metabolism and Pharmacokinetics, 2002, 27 : 37 - 43
  • [2] Renal metabolism of 111In-DTPA-D-Phe1-octreotide in vivo
    Akizawa, H
    Arano, Y
    Uezono, T
    Ono, M
    Fujioka, Y
    Uehara, T
    Yokoyama, A
    Akaji, K
    Kiso, Y
    Koizumi, M
    Saji, H
    BIOCONJUGATE CHEMISTRY, 1998, 9 (06) : 662 - 670
  • [3] 111In-DTPA-D-Phe1-octreotide的动物实验
    王凡
    陈方
    肖伦
    樊红强
    金小海
    王翌善
    陈大明
    白宏升
    李家秀
    刘琳
    核技术, 1998, (05) : 293 - 296
  • [4] 111In-DTPA-D-Phe-1-Asp0-D-Phe1-octreotide exhibits higher tumor accumulation and lower renal radioactivity than 111In-DTPA-D-Phe1-octreotide
    Oshima, Nobuhiro
    Akizawa, Hiromichi
    Kitaura, Hirotake
    Kawashima, Hidekazu
    Zhao, Songji
    Zhao, Yan
    Nishijima, Ken-ichi
    Kitamura, Yoji
    Arano, Yasushi
    Kuge, Yuji
    Ohkura, Kazue
    NUCLEAR MEDICINE AND BIOLOGY, 2017, 54 : 18 - 26
  • [5] DISTRIBUTION AND ELIMINATION OF THE SOMATOSTATIN ANALOG (IN-111-DTPA-D-PHE(1))-OCTREOTIDE (OCTREOSCAN111)
    ARNBERG, H
    WESTLIN, JE
    HUSIN, S
    NILSSON, S
    ACTA ONCOLOGICA, 1993, 32 (02) : 177 - 182
  • [6] 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors
    Forssell-Aronsson, EB
    Nilsson, O
    Benjegård, SA
    Kölby, LK
    Bernhardt, P
    Mölne, J
    Hashemi, SH
    Wängberg, B
    Tisell, LE
    Ahlman, H
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (04) : 636 - 642
  • [7] Intraoperative tumour detection using 111In-DTPA-D-Phe1-octreotide and a scintillation detector
    Sven Benjegård
    Eva Forssell-Aronsson
    Bo Wängberg
    Jan Skånberg
    Ola Nilsson
    Håkan Ahlman
    European Journal of Nuclear Medicine, 2001, 28 : 1456 - 1462
  • [8] The pituitary uptake of 111In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas
    A. Colao
    S. Lastoria
    D. Ferone
    P. Varrella
    P. Marzullo
    R. Pivonello
    G. Cerbone
    W. Acampa
    M. Salvatore
    G. Lombardi
    Journal of Endocrinological Investigation, 1999, 22 : 176 - 183
  • [9] The pituitary uptake of 111In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas
    Colao, A
    Lastoria, S
    Ferone, D
    Varrella, P
    Marzullo, P
    Pivonello, R
    Cerbone, G
    Acampa, W
    Salvatore, M
    Lombardi, G
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1999, 22 (03) : 176 - 183
  • [10] Intraoperative tumour detection using 111In-DTPA-D-Phe1-octreotide and a scintillation detector
    Benjegård, SA
    Forssell-Aronsson, E
    Wängberg, B
    Skånberg, J
    Nilsson, O
    Ahlman, H
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (10) : 1456 - 1462